H&H國際(01112.HK)首三季總收入91.8億人幣 按年升13.4%
H&H國際(01112.HK)公布,截至今年9月底止首三季總收入達到91.84億元人民幣,按年增長13.4%,若按同類比較基準則升7.8%。公司表示,收入錄得增長主要歸因於內地、澳洲及新西蘭成人營養及護理用品分部的穩健增長、寵物營養及護理用品業務持續的強勁升勢,以及嬰幼兒營養及護理用品分部日趨穩定。
期內來自內地的收入按同類比較基準按年增長7.3%,澳洲及新西蘭按同類比較基準合計增長20.6%,而北美地區收入按同類比較基準則按年增長20.2%。
集團表示,透過交叉貨幣掉期及利率掉期對沖兩項債務工具到期前的相關風險,有能力應對較大的匯率波動及較高的利率環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.